We gratefully acknowledge support from
the Simons Foundation and member institutions.
Full-text links:

Download:

Current browse context:

q-bio.TO

Change to browse by:

References & Citations

Bookmark

(what is this?)
CiteULike logo BibSonomy logo Mendeley logo del.icio.us logo Digg logo Reddit logo ScienceWISE logo

Quantitative Biology > Tissues and Organs

Title: Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment

Abstract: A novel multifunctional nanodevice based in doxorubicin (DOX)- loaded mesoporous silica nanoparticles (MSNs) as nanoplatforms for the assembly of different building blocks has been developed for bone cancer treatment. These building blocks consists of: i) a polyacrylic acid (PAA) capping layer grafted to MSNs via an acid-cleavable acetal linker, to minimize premature cargo release and provide the nanosystem of pHresponsive drug delivery ability; and ii) a targeting ligand, the plant lectin concanavalin A (ConA), able to selectively recognize, bind and internalize owing to certain cell-surface glycans, such as sialic acids (SA), overexpressed in given tumor cells. This multifunctional nanosystem exhibits a noticeable higher internalization degree into human osteosarcoma cells (HOS), overexpressing SA, compared to healthy preosteoblast cells (MC3T3-E1). Moreover, the results indicate that small DOX loading leads to almost 100% of osteosarcoma cell death in comparison with healthy bone cells, which significantly preserve their viability. Besides, this nanodevice has a cytotoxicity on tumor cells 8- fold higher than that caused by the free drug. These findings demonstrate that the synergistic combination of different building blocks into a unique nanoplatform increases antitumor effectiveness and decreases toxicity towards normal cells. This line of attack opens up new insights in targeted bone cancer therapy.
Comments: 41 pages, 7 figures
Subjects: Tissues and Organs (q-bio.TO)
Journal reference: Acta Biomaterialia. 65, 393-404 (2018)
DOI: 10.1016/j.actbio.2017.11.007
Cite as: arXiv:2103.10190 [q-bio.TO]
  (or arXiv:2103.10190v1 [q-bio.TO] for this version)

Submission history

From: María Vallet-Regi [view email]
[v1] Thu, 18 Mar 2021 11:56:28 GMT (1067kb)

Link back to: arXiv, form interface, contact.